rs554561970

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001370096.2(SBK2):​c.629G>T​(p.Arg210Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,506,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

SBK2
NM_001370096.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0260

Publications

1 publications found
Variant links:
Genes affected
SBK2 (HGNC:34416): (SH3 domain binding kinase family member 2) Predicted to enable MAP kinase kinase activity. Predicted to be involved in MAPK cascade and protein phosphorylation. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.056158155).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SBK2NM_001370096.2 linkc.629G>T p.Arg210Leu missense_variant Exon 4 of 4 ENST00000413299.6 NP_001357025.1
SBK2XM_011527227.3 linkc.*188G>T 3_prime_UTR_variant Exon 4 of 4 XP_011525529.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SBK2ENST00000413299.6 linkc.629G>T p.Arg210Leu missense_variant Exon 4 of 4 5 NM_001370096.2 ENSP00000389015.2 P0C263
SBK2ENST00000344158.4 linkc.629G>T p.Arg210Leu missense_variant Exon 3 of 3 2 ENSP00000345044.3 P0C263

Frequencies

GnomAD3 genomes
AF:
0.000611
AC:
93
AN:
152160
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000128
AC:
13
AN:
101914
AF XY:
0.000142
show subpopulations
Gnomad AFR exome
AF:
0.00128
Gnomad AMR exome
AF:
0.000414
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000323
GnomAD4 exome
AF:
0.0000443
AC:
60
AN:
1354504
Hom.:
0
Cov.:
34
AF XY:
0.0000345
AC XY:
23
AN XY:
666258
show subpopulations
African (AFR)
AF:
0.00117
AC:
33
AN:
28254
American (AMR)
AF:
0.000462
AC:
14
AN:
30288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22800
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33628
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74262
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41566
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5486
European-Non Finnish (NFE)
AF:
9.42e-7
AC:
1
AN:
1062086
Other (OTH)
AF:
0.000196
AC:
11
AN:
56134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.000470
AC XY:
35
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00200
AC:
83
AN:
41562
American (AMR)
AF:
0.000523
AC:
8
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68008
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000870
Hom.:
0
Bravo
AF:
0.000767
ExAC
AF:
0.0000348
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 16, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.629G>T (p.R210L) alteration is located in exon 4 (coding exon 3) of the SBK2 gene. This alteration results from a G to T substitution at nucleotide position 629, causing the arginine (R) at amino acid position 210 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.015
T;T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.85
D;.
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.056
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.63
N;N
PhyloP100
-0.026
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.17
Sift
Benign
0.13
T;T
Sift4G
Benign
0.17
T;T
Polyphen
0.90
P;P
Vest4
0.43
MutPred
0.58
Loss of methylation at R210 (P = 0.0213);Loss of methylation at R210 (P = 0.0213);
MVP
0.52
MPC
2.3
ClinPred
0.057
T
GERP RS
4.0
Varity_R
0.12
gMVP
0.52
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs554561970; hg19: chr19-56041518; API